Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $401.71 USD
Change Today -28.57 / -6.64%
Volume 6.1M
BIIB On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven H. Holtzman D.Phil.

Executive Vice President of Corporate Development, Biogen Inc.
AgeTotal Calculated CompensationThis person is connected to 128 board members in 5 different organizations across 11 different industries.

See Board Relationships
60--

Background*

Mr. Steven H. Holtzman, also known as Steve, D.Phil. has been an Executive Vice President of Corporate Development of Biogen Inc. since January 5, 2011. Mr. Holtzman has substantial experience in building collaborations with major pharmaceutical companies and licensing products. He founded Infinity Pharmaceuticals Inc. in 2006 and served as its Executive Chairman and also served as its Non-Executive Chairman since December 31, 2010, Chairman of the Board from September ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

Former Director
Founder
Director
Director
2004-2011
Former Chairman of the Board and Chairman of Compensation Committee
2009-Present
Chairman
2014-Present
Director
2014-Present
Director

Education*

BA
Michigan State University
PhB 1976
University of Oxford
PhD
University of Oxford

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB:US $401.71 USD -28.57

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.